The company recently released an RUO RNA extraction kit, and plans to launch a liquid biopsy pan-cancer test and disease-specific NGS panels later this year.
A 400-sample retrospective analysis in invasive breast cancer will inform a basket trial that the Ontario Institute for Cancer Research hopes to soon launch.
Harvard researchers found that variants previously classified as pathogenic were in fact benign, disproportionately affecting patients of African ancestry.
The technique will use optical maps and barcodes in order to generate long scaffolds from short-read sequencing technology.
The Sydney-based genomics center is implementing diagnostic sequencing pipelines and figuring out best practices for incorporating genomics into healthcare.
In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.
Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.
MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.
Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.